» Articles » PMID: 6370765

Type 2 (non-insulin-dependent) Diabetes Mellitus and Coronary Heart Disease-chicken, Egg or Neither?

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1984 Feb 1
PMID 6370765
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

review of the literature yields much evidence against a correlation between duration of non-insulin-dependent diabetes mellitus (Type 2 diabetes) and the degree of coronary atherosclerosis or the risk of clinically evident coronary heart disease (CHD). Furthermore, an increased risk of CHD, similar to that in previously diagnosed diabetic subjects, has been demonstrated in persons with impaired glucose tolerance. These observations suggest that an increased risk of CHD is not a consequence of the development of diabetes (i.e. persistent hyperglycaemia). It is more likely that diabetes develops in individuals who already possess characteristics which increase the risk of CHD in addition to the risk of developing diabetes.

Citing Articles

A new kid in town: Cardiovascular Diabetology-Endocrinology Reports.

Fisman E, Westermeier F, Santulli G Cardiovasc Diabetol. 2025; 24(1):30.

PMID: 39844290 PMC: 11755897. DOI: 10.1186/s12933-025-02602-1.


Risk factors and predictive model construction for lower extremity arterial disease in diabetic patients.

Kuang Y, Cheng Z, Zhang J, Yang C, Zhang Y PLoS One. 2025; 19(12):e0314862.

PMID: 39775606 PMC: 11684652. DOI: 10.1371/journal.pone.0314862.


Dapagliflozin and sacubitril on myocardial microperfusion in patients with post-acute myocardial infarction heart failure and type 2 diabetes.

Lv Y, Luo W World J Clin Cases. 2024; 12(22):5008-5015.

PMID: 39109007 PMC: 11238782. DOI: 10.12998/wjcc.v12.i22.5008.


Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers.

Prandi F, Lecis D, Illuminato F, Milite M, Celotto R, Lerakis S Int J Mol Sci. 2022; 23(9).

PMID: 35562979 PMC: 9105558. DOI: 10.3390/ijms23094589.


Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women.

Tobias D, Lawler P, Harada P, Demler O, Ridker P, Manson J Circ Genom Precis Med. 2018; 11(4):e002157.

PMID: 29572205 PMC: 5880282. DOI: 10.1161/CIRCGEN.118.002157.


References
1.
Fuller J, Shipley M, Rose G, Jarrett R, Keen H . Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980; 1(8183):1373-6. DOI: 10.1016/s0140-6736(80)92651-3. View

2.
Jarrett R, Keen H, Fuller J, McCartney M . Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"). Diabetologia. 1979; 16(1):25-30. DOI: 10.1007/BF00423146. View

3.
Jarrett R, Keen H, McCartney M, Fuller J, Hamilton P, Reid D . Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol. 1978; 7(1):15-24. DOI: 10.1093/ije/7.1.15. View

4.
Jarrett R, McCartney P, Keen H . The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 1982; 22(2):79-84. DOI: 10.1007/BF00254833. View

5.
Sayegh H, Jarrett R . Oral glucose-tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey. Lancet. 1979; 2(8140):431-3. DOI: 10.1016/s0140-6736(79)91489-2. View